These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22553402)

  • 41. Vascular endothelial growth factor: Evidence for autocrine signaling in hepatocellular carcinoma cell lines affecting invasion.
    Sharma BK; Srinivasan R; Chawla YK; Chakraborti A
    Indian J Cancer; 2016; 53(4):542-547. PubMed ID: 28485347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis.
    Wang F; Fei H; Qi B; Yao S; Chang Z
    Mol Cell Biochem; 2012 May; 364(1-2):165-71. PubMed ID: 22209835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma.
    Yaser AM; Huang Y; Zhou RR; Hu GS; Xiao MF; Huang ZB; Duan CJ; Tian W; Tang DL; Fan XG
    Int J Mol Sci; 2012; 13(5):5982-5997. PubMed ID: 22754344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2013 May; 45(5):387-90. PubMed ID: 23225247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma.
    von Marschall Z; Cramer T; Höcker M; Finkenzeller G; Wiedenmann B; Rosewicz S
    Gut; 2001 Jan; 48(1):87-96. PubMed ID: 11115828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.
    Tian T; Nan KJ; Wang SH; Liang X; Lu CX; Guo H; Wang WJ; Ruan ZP
    Carcinogenesis; 2010 Jul; 31(7):1211-9. PubMed ID: 20430845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma.
    Cheng CC; Chao WT; Shih JH; Lai YS; Hsu YH; Liu YH
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):143-153. PubMed ID: 33860837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
    Liang H; Zhong Y; Zhou S; Peng L
    Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
    Buijs N; Oosterink JE; Jessup M; Schierbeek H; Stolz DB; Houdijk AP; Geller DA; van Leeuwen PA
    Angiogenesis; 2017 Nov; 20(4):557-565. PubMed ID: 28741166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro.
    Aljohi A; Matou-Nasri S; Liu D; Al-Khafaji N; Slevin M; Ahmed N
    Food Funct; 2018 Nov; 9(11):5728-5739. PubMed ID: 30318521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation.
    Boulanger E; Grossin N; Wautier MP; Taamma R; Wautier JL
    Kidney Int; 2007 Jan; 71(2):126-33. PubMed ID: 17149374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
    Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
    Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma.
    Gorrin-Rivas MJ; Arii S; Mori A; Takeda Y; Mizumoto M; Furutani M; Imamura M
    Ann Surg; 2000 Jan; 231(1):67-73. PubMed ID: 10636104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.
    Kunanopparat A; Issara-Amphorn J; Leelahavanichkul A; Sanpavat A; Patumraj S; Tangkijvanich P; Palaga T; Hirankarn N
    World J Gastroenterol; 2018 Sep; 24(34):3861-3870. PubMed ID: 30228780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway.
    Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC
    Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways.
    Chen H; Liu W; Wu X; Gou M; Shen J; Wang H
    Int Immunopharmacol; 2017 Nov; 52():143-149. PubMed ID: 28910744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.
    Kong J; Kong L; Kong J; Ke S; Gao J; Ding X; Zheng L; Sun H; Sun W
    J Transl Med; 2012 Nov; 10():230. PubMed ID: 23171368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.